Stockerblog.com Gene Therapy Stocks
170 views
Rate Now: 1 2 3 4

average rating: 0.00 / 0 ratings
Created by stockerblog
DESCRIPTION:

Date updated:05-10-2008

Stocks of companies involved in gene therapy, including stem cell companies and cord blood companies. By Stockerblog.com

symbol name last price % change open
  • +
  • ALNY
    Alnylam Pharmaceu
  • $22.62
  • -0.57%
  • $22.46

develops therapeutic products based on RNA interference

People owning ALNY also tend to own: AVNXTIVOSHLDSPLSAUYUPLCOP

TheStreet.com Rating: D What is this?

  • +
  • CEGE
    Cell Genesys Inc
  • $0.13
  • -16.13%
  • $0.16

a biotechnology company that develops cell-based cancer immunotherapies and oncolytic virus therapies

People owning CEGE also tend to own: CAMPELNKFCELIDIXJBLUTALKTIE

TheStreet.com Rating: D What is this?

  • +
  • ENZ
    Enzo Biochem Inc
  • $5.21
  • -5.96%
  • $5.37

biomedical research products and tools used in the fields of gene expression

People owning ENZ also tend to own: AMKRANADBDYCBAKFRGIOCNRMX

TheStreet.com Rating: C- What is this?

  • +
  • GENZ
    Genzyme Corporati
  • $66.11
  • -3.23%
  • $68.67

products and therapies relating to renal, therapeutics, transplants, biosurgery, and genetics

People owning GENZ also tend to own: LRCXWRLDAMGNDNAAMZNBLUDHPQ

TheStreet.com Rating: C+ What is this?

  • +
  • ISIS
    Isis Pharm Inc
  • $13.58
  • -2.65%
  • $13.66

RNA-based drugs

People owning ISIS also tend to own: NYXSAIEMNTGCTRCADVNMEDX

TheStreet.com Rating: D- What is this?

  • +
  • ONXX
    Onyx Pharm Inc
  • $27.36
  • -5.52%
  • $28.59

oral anticancer therapies used to prevent cancer cell proliferation and angiogenesis

People owning ONXX also tend to own: AAADMCCRTCVXEWBCFMDMRO

TheStreet.com Rating: D What is this?

 

Start Price

Return Value

Start Date

ALNY 27.67 -18.25% May 10th
CEGE 3.90 -96.67% May 10th
ENZ 9.13 -42.94% May 10th
GENZ 69.54 -4.93% May 10th
ISIS 11.77 +15.38% May 10th
ONXX 34.87 -21.54% May 10th

Average return:

-28.16%

Success rate:

16.67%

Tracking Started: 05-10-2008

Comments not available

ADD YOUR COMMENTS:

Top Biotech Short-Squeeze Plays

One industry that is expected to do well in a Barack Obama presidency is biotech. With the drop in the stock market bringing down all stocks, including the biotechs, short-...

11.20.08 | 18:30 PM
Cramer's Take on Top-Searched St...

As if Wednesday's blood bath wasn't enough, Wall Street was further rattled on Thursday after the Labor Department reported that new claims for unemployment benefits climbe...

11.20.08 | 17:59 PM
Jim Cramer's Portfolios of the Week

Jim Cramer has no problem with remaining in the bear camp on Wall Street. Recently, he spotted a new crisis on the horizon for the commercial real estate market, and on Thu...

11.20.08 | 17:11 PM
Approach China Medical With Caution

Financial research is never a simple task. It requires a substantial time commitment to read over a company's recent filings and listen to its investor presentation, as we...

11.20.08 | 14:15 PM
more articles
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZackAttack
Will black social ills take a ba...
11.22.08 | 18:53 PM From author Valerie Vecchio
Dear crooked CEO
11.19.08 | 17:17 PM From author srea
Anarchy Stock Market
11.20.08 | 21:32 PM From author silversliver
more forums
Q. 3 more banks fail! http://ww...
11.22.08 | 17:21 PM Asked by michael morse

A. so.....if fed thinks its okay for USB to
pick up the tab for 2 of the
banks....should you still be worried
about USB? i might add that one to my
financials that i'm collecting.

today 's lists
Top Stock Buybacks

This is a portfolio of stocks that consist of the top stock buybacks announced in the prior week. This will be updated every Friday. more

Low Priced NYSE Stocks

This portfolio consists of NYSE stocks that are trading for less than $5 per share and are profitable. more

TSC Ratings Upgrades

These stocks were upgraded at TheStreet.com Ratings on Nov. 19. Click here for more information about the ratings' changes.... more